Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

NCT05108974 is registered in ClinicalTrials.gov with Jeff Wozniak as lead sponsor.

NCT NCT05108974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05108974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
Lead sponsor
Jeff Wozniak
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 22, 2021
Completion date
July 31, 2027
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal alcohol spectrum disorders